Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is colorectal cancer?
The colon and rectum form the last several feet of the digestive tract, absorbing water and storing waste. Most colorectal cancers begin as a polyp — a small growth on the inner lining — that slowly turns cancerous over years. Because that change is slow, screening (like a colonoscopy) can find and remove polyps before cancer ever develops, or catch cancer early when it is highly curable. Where the tumor sits matters: rectal cancers are low in the pelvis and often involve radiation, while colon cancers higher up usually do not.
The main types
Doctors group colorectal cancer by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Adenocarcinoma | Over 95% of cases; starts in the gland cells lining the colon or rectum, usually from a polyp. |
| Rectal vs. colon cancer | Same family, different location — rectal cancer sits in the last few inches and more often needs radiation because of the tight pelvic space. |
| Rarer types | Carcinoid (neuroendocrine), gastrointestinal stromal tumors (GIST), and lymphoma can also arise here but are uncommon. |
Staging, in plain terms
Staging uses T (how deep the tumor grows through the bowel wall), N (lymph nodes involved), and M (metastasis/distant spread). How deep it has grown and whether nodes are involved guide whether radiation, chemo, or surgery alone is needed.
| TNM | What it generally means |
|---|---|
| Stage 0 | Earliest cancer, confined to the innermost lining. Often cured by removing it during colonoscopy. |
| Stage I | Grown into the wall but not through it, with no lymph-node spread. Usually cured with surgery alone. |
| Stage II | Grown through the bowel wall but lymph nodes are still clear. |
| Stage III | Spread to nearby lymph nodes. Treated with surgery plus chemotherapy (and radiation for rectal cancer). |
| Stage IV | Spread to distant organs such as the liver or lungs. Often still treatable, sometimes with intent to cure if spread is limited. |
The standard of care
Colorectal Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery
The main treatment — removing the section of bowel containing the tumor along with nearby lymph nodes. Most people keep normal bowel function.
Radiation therapy (mainly rectal)
For rectal cancer, radiation (often with chemo) before surgery shrinks the tumor, lowers recurrence, and can even avoid surgery in some responders.
Systemic medicine
Chemotherapy for stage III and IV disease; targeted drugs and immunotherapy matched to the tumor's biomarkers (such as MSI-high or RAS status).
How radiation treatment works
Radiation uses focused high-energy x-rays to damage cancer-cell DNA so the cells can no longer divide. Healthy cells repair this damage better than cancer cells, so fractionated treatment clears cancer while sparing normal tissue. For rectal cancer, modern image-guided techniques aim the dose tightly to protect the bladder, small bowel, and surrounding organs. Sessions are painless and brief; side effects can include temporary loose stools, mild skin irritation, and fatigue that settle after treatment.
The main ways radiation is delivered for colorectal cancer:
Neoadjuvant chemoradiation (rectal)
Combines daily radiation over about 5 weeks with chemotherapy before surgery to shrink the tumor and dramatically reduce local recurrence.
Short-course radiation (rectal)
A faster five-day radiation schedule, often as part of 'total neoadjuvant therapy,' that is more convenient and equally effective for suitable patients.
SBRT for oligometastases
Precise high-dose radiation can ablate a small number of spots in the liver or lung when colorectal cancer spreads to only a few places.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Total neoadjuvant therapy (TNT): Giving all chemotherapy and radiation before surgery improves outcomes for locally advanced rectal cancer and raises the chance of a complete response.[1]
RAPIDO and PRODIGE 23 trials · PMID 33301740 (opens in a new tab)
Watch-and-wait after complete response: Some rectal-cancer patients whose tumor disappears after chemoradiation can safely avoid surgery and keep their rectum under close monitoring.[2]
International Watch & Wait Database · PMID 29976470 (opens in a new tab)
Screening is moving earlier: Because colorectal cancer is rising in younger adults, guidelines now recommend starting screening at age 45 for people at average risk.[3]
US Preventive Services Task Force · PMID 34003218 (opens in a new tab)
Common questions
Will I need a permanent colostomy bag? Most people do not. Modern surgery preserves bowel function for the majority; a permanent bag is needed only in select low rectal tumors, and your team will discuss this in advance.
Does colon cancer need radiation? Usually no — colon cancer is treated with surgery and sometimes chemo. Radiation is mainly used for rectal cancer because of its location in the pelvis.
When should I get screened? At average risk, start at age 45. Screening can remove polyps before they turn into cancer, making it one of the most effective cancer-prevention tools we have.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Meershoek-Klein Kranenbarg E, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29-42. Companion trial: Conroy T, Bosset JF, Etienne PL, et al. UNICANCER-PRODIGE 23. Lancet Oncol. 2021;22(5):702-715 (PMID 33862000). (opens in a new tab) PMID 33301740 ↩
- van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537-2545. (opens in a new tab) PMID 29976470 ↩
- US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. (opens in a new tab) PMID 34003218 ↩
